These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9448079)

  • 1. Simultaneous quantitation of plasma doxorubicin and prochlorperazine content by high-performance liquid chromatography.
    Mou C; Ganju N; Sridhar KS; Krishan A
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):217-24. PubMed ID: 9448079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography.
    Chin DL; Lum BL; Sikic BI
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):259-69. PubMed ID: 12361740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography-electrospray mass spectrometry.
    Lachâtre F; Marquet P; Ragot S; Gaulier JM; Cardot P; Dupuy JL
    J Chromatogr B Biomed Sci Appl; 2000 Feb; 738(2):281-91. PubMed ID: 10718646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations.
    Wei G; Xiao S; Si D; Liu C
    Biomed Chromatogr; 2008 Nov; 22(11):1252-8. PubMed ID: 18651589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subnanogram quantitation of chlorpromazine in plasma by high-performance liquid chromatography with electrochemical detection.
    Cooper JK; McKay G; Midha KK
    J Pharm Sci; 1983 Nov; 72(11):1259-62. PubMed ID: 6644586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of epirubicin, doxorubicin and their principal metabolites in human plasma by high-performance liquid chromatography and electrochemical detection.
    Ricciarello R; Pichini S; Pacifici R; Altieri I; Pellegrini M; Fattorossi A; Zuccaro P
    J Chromatogr B Biomed Sci Appl; 1998 Apr; 707(1-2):219-25. PubMed ID: 9613953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.
    Fogli S; Danesi R; Innocenti F; Di Paolo A; Bocci G; Barbara C; Del Tacca M
    Ther Drug Monit; 1999 Jun; 21(3):367-75. PubMed ID: 10365655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of prochlorperazine maleate in human plasma by liquid chromatography-mass spectrometry: Application to a bioequivalence study.
    Yan M; Zhu YG; Li HD; Chen BM; Ma N; Lei YQ; Liu YP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3243-7. PubMed ID: 19682959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loop-column extraction and liquid chromatographic analysis of doxorubicin and three metabolites in plasma.
    Riley CA; Crom WR; Evans WE
    Ther Drug Monit; 1985; 7(4):455-60. PubMed ID: 4082243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of idarubicin and idarubicinol in rat plasma using reversed-phase high-performance liquid chromatography and fluorescence detection.
    Kuhlmann O; Hofmann S; Weiss M
    J Chromatogr B Biomed Sci Appl; 1999 May; 728(2):279-82. PubMed ID: 10406213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of prochlorperazine and dipyridamole on the cellular retention and cytotoxicity of doxorubicin.
    Krishan A; Sridhar KS; Mou C; Stein WD; Lyubimov E; Hu YP; Fernandez H
    Clin Cancer Res; 2000 Apr; 6(4):1508-17. PubMed ID: 10778983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography.
    de Bruijn P; Verweij J; Loos WJ; Kolker HJ; Planting AS; Nooter K; Stoter G; Sparreboom A
    Anal Biochem; 1999 Jan; 266(2):216-21. PubMed ID: 9888978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of a new anthracycline, DA-125, and its metabolites M1, M2, M3 and M4 in plasma and urine by high-performance liquid chromatography.
    Shim HJ; Lee ED; Yoon EJ; Lee SD; Kim WB; Yang J; Lee MG
    J Chromatogr B Biomed Appl; 1994 Jun; 656(2):407-14. PubMed ID: 7987494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of 3'-deamino-3'-[2(S)-methoxy-4-morpholinyl]doxorubicin, a new morpholinyl anthracycline, in plasma by high-performance liquid chromatography with fluorescence detection.
    Breda M; Pianezzola E; Benedetti MS
    J Chromatogr; 1992 Jul; 578(2):309-15. PubMed ID: 1400812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of prochlorperazine and its metabolites in human plasma using isocratic liquid chromatography tandem mass spectrometry.
    Tashiro M; Naito T; Kagawa Y; Kawakami J
    Biomed Chromatogr; 2012 Jun; 26(6):754-60. PubMed ID: 21990013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE.
    Sottani C; Poggi G; Melchiorre F; Montagna B; Minoia C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 915-916():71-8. PubMed ID: 23337906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous high-performance liquid chromatographic determination of a glucuronyl prodrug of doxorubicin, doxorubicin and its metabolites in human lung tissue.
    Mürdter TE; Sperker B; Bosslet K; Fritz P; Kroemer HK
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(2):289-95. PubMed ID: 9657226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography.
    van Asperen J; van Tellingen O; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):129-43. PubMed ID: 9698235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker.
    Sridhar KS; Krishan A; Samy TS; Duncan RC; Sauerteig A; McPhee GV; Auguste ME; Benedetto PW
    Cancer Chemother Pharmacol; 1994; 34(5):377-84. PubMed ID: 8070004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of doxorubicin, daunorubicin, and idarubicin by capillary electrophoresis with laser-induced fluorescence detection.
    Pérez-Ruiz T; Martínez-Lozano C; Sanz A; Bravo E
    Electrophoresis; 2001 Jan; 22(1):134-8. PubMed ID: 11197162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.